Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-12-12
DOI
10.1038/s41467-018-07199-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of an Escherichia coli -derived human papillomavirus type 16 and 18 bivalent vaccine
- (2017) Ying Gu et al. VACCINE
- Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
- (2017) Zhihai Li et al. mBio
- Gctf: Real-time CTF determination and correction
- (2016) Kai Zhang JOURNAL OF STRUCTURAL BIOLOGY
- The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction
- (2016) Zhihai Li et al. STRUCTURE
- Next generation prophylactic human papillomavirus vaccines
- (2015) John T Schiller et al. LANCET ONCOLOGY
- Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization
- (2015) Jian Guan et al. VIROLOGY
- Eliciting broadly protective antibody responses against influenza
- (2014) Greg A Kirchenbaum et al. CURRENT OPINION IN IMMUNOLOGY
- Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®): A Review of Its Use in the Prevention of Premalignant Anogenital Lesions, Cervical and Anal Cancers, and Genital Warts
- (2014) Paul L. McCormack DRUGS
- Human Papillomavirus Type 16 Pseudovirions with Few Point Mutations in L1 Major Capsid Protein FG Loop Could Escape Actual or Future Vaccination for Potential Use in Gene Therapy
- (2014) Maxime J. J. Fleury et al. MOLECULAR BIOTECHNOLOGY
- Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins
- (2014) Sara L. Bissett et al. VACCINE
- Cross-roads in the classification of papillomaviruses
- (2013) Ethel-Michele de Villiers VIROLOGY
- Evolution of the Papillomaviridae
- (2013) Koenraad Van Doorslaer VIROLOGY
- RELION: Implementation of a Bayesian approach to cryo-EM structure determination
- (2012) Sjors H.W. Scheres JOURNAL OF STRUCTURAL BIOLOGY
- Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
- (2012) D. R. Burton et al. SCIENCE
- Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity
- (2012) Yixin Chen et al. VACCINE
- Human Papillomavirus Testing in the Prevention of Cervical Cancer
- (2011) Mark Schiffman et al. JNCI-Journal of the National Cancer Institute
- MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods
- (2011) K. Tamura et al. MOLECULAR BIOLOGY AND EVOLUTION
- Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
- (2011) F. Sievers et al. Molecular Systems Biology
- HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
- (2011) Troy J. Kemp et al. VACCINE
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine
- (2010) Michel Deschuyteneer et al. Human vaccines & immunotherapeutics
- Analysis of Host–Parasite Incongruence in Papillomavirus Evolution Using Importance Sampling
- (2010) Seena D. Shah et al. MOLECULAR BIOLOGY AND EVOLUTION
- Chemical synthesis of the mouse mitochondrial genome
- (2010) Daniel G Gibson et al. NATURE METHODS
- Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
- (2010) G. Bommakanti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
- (2010) Subhashini Jagu et al. VACCINE
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
- (2010) J. Steel et al. mBio
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Papillomaviruses in the causation of human cancers — a brief historical account
- (2009) Harald zur Hausen VIROLOGY
- Neutralizing Antibodies against Human Papillomavirus Types 16, 18, 31, 52, and 58 in Serum Samples from Women in Japan with Low-Grade Cervical Intraepithelial Neoplasia
- (2008) H. Ochi et al. Clinical and Vaccine Immunology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now